BDX
What one share of Becton, Dickinson And holds
Surgical and Medical Instruments and Apparatus
BD is a global medical technology company engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Becton, Dickinson And’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $79.39 |
|---|---|
| Profit | $3.33 |
| Capex (buildings and equipment) | $2.66 |
| Free cash flow | $11.31 |
| Dividends | $4.19 |
| Cash and investments | $2.60 |
| Debt | $49.60 |
| Book value | $89.64 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $57.38 | $4.49 | $3.19 | $8.58 | $2.64 | $35.95 |
| 2017 | $54.09 | $4.61 | $3.25 | $8.15 | $2.92 | $56.79 |
| 2018 | $60.40 | $0.60 | $3.38 | $7.44 | $3.00 | $78.26 |
| 2019 | $62.92 | $3.94 | $3.48 | $8.64 | $3.08 | $77.94 |
| 2020 | $56.92 | $2.72 | $2.72 | $9.81 | $3.16 | $81.94 |
| 2021 | $65.50 | $6.85 | $4.09 | $11.82 | $3.32 | $83.36 |
| 2022 | $65.67 | $5.88 | $3.39 | $5.21 | $3.48 | $89.22 |
| 2023 | $67.17 | $4.94 | $3.03 | $7.34 | $3.64 | $88.83 |
| 2024 | $69.34 | $5.86 | $2.49 | $10.72 | $3.80 | $89.55 |
| 2025 | $75.70 | $5.82 | $2.63 | $9.25 | $4.16 | $88.96 |